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ABSTRACT
Objectives: There was a large outbreak of measles in
Liverpool, UK, in 2012–2013, despite measles, mumps
and rubella (MMR) immunisation uptake rates that
were higher than the national average. We estimated
measles susceptibility of a cohort of children born in
Liverpool between 1995 and 2012 to understand
whether there was a change in susceptibility before
and after the outbreak and to inform vaccination
strategy.
Design: Retrospective cohort study.
Setting: The city of Liverpool, North West UK.
Participants: All children born in Liverpool (72 101)
between 1995 and 2012 inclusive who were identified
using the Child Health Information System (CHIS) and
were still resident within Liverpool in 2014.
Primary and secondary outcome measures:
We estimated cohort age-disaggregated and
neighbourhood-disaggregated measles susceptibility
according to WHO thresholds before and after the
outbreak for children aged 1–17 years.
Results: Susceptibility to measles was above WHO
elimination thresholds before and after the measles
outbreak in the 10+ age group. The proportion of
children susceptible before and after outbreak,
respectively: age 1–4 years 15.0% before and 14.9%
after; age 5–9 years 9.9% before and 7.7% after; age
10+ years 8.6% before and 8.5% after. Despite an
intensive MMR immunisation catch-up campaign after
the 2012–2013 measles outbreak, the overall
proportion of children with no MMR remains high at
6.1% (4390/72 351). Across all age groups and
before and after the outbreak, measles
susceptibility was clustered by neighbourhood, with
deprived areas having the greatest proportion of
susceptible children.
Conclusions: The risk of sustained measles
outbreaks remains, especially as large pools of
susceptible older children will start leaving secondary
education and continue to aggregate in higher
education, employment and other community settings
and institutions resulting in the potential for a
propagated measles outbreak.
INTRODUCTION
Measles is highly infectious, yet is prevent-
able through the measles component of the
measles, mumps and rubella (MMR) vaccine.
The measles vaccine was introduced in
England in 1968 and led to an immediate
reduction in cases of, and deaths attributed
to, measles. MMR vaccination was introduced
in the UK in 1988 as a single dose, with a
second dose introduced in 1996.1 At present,
in the UK, MMR is offered as a single dose at
13 months (MMR1) with the second dose
offered at 40 months (MMR2).2 Routine mon-
itoring data collected in England, COVER
data3 have shown that by 1995, the uptake of
a single dose of MMR reached a plateau at
∼92% within the UK at 2 years of age.
The prevention of spread of measles
requires low levels of population susceptibil-
ity, most effectively achieved through a
minimum of 95% uptake of second dose of
MMR. In 1998, a paper claimed an alleged
Strengths and limitations of this study
▪ This is a robust, prospectively collected data set
comprising individual-level data on over 70 000
children over a period of 18 years.
▪ This is a simple, repeatable and resource light data
source and methodology assessing local area level
susceptibility of vaccine preventable diseases that
could be used by researchers, public health com-
missioners and policymakers across the UK.
▪ We excluded infants too young for MMR1 at
each time point as they were ineligible for
measles, mumps and rubella vaccination,
meaning that measles susceptibility may be
underestimated.
▪ We did not account for age–sex and geospatial
mixing patterns that may influence the risk of
measles susceptibility and infection.
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association between MMR and autism.4 The methods
used and the alleged association were ﬂawed, and widely
criticised5 6 and the paper was subsequently discredited
and retracted, with further studies showing no evidence
of associations between MMR and either autism or
bowel disease.7–10 However, the ﬁndings of this paper
adversely affected MMR vaccination uptake across the
UK, and MMR uptake remained below herd protection
levels for several years.11
In 2012, the city of Liverpool had an estimated popu-
lation of 469 690, and 83 344 (18%) were between the
ages of 1 and 17 years.12 In Liverpool, MMR1 uptake at
2 years of age was 89.2% in 1997–1998 and this declined
to 79.2% in 2003–2004, but subsequently improved to
96.0% in 2012–2013.11 The uptake of MMR2 at 5 years
of age was 67.7% in 1999–2000 when records began,
and dropped to 61.7% in 2003–2004, before increasing
to 91.5% in 2012–2013. Liverpool has had above
national average uptake for MMR1 for over a decade,11
but this was still below the 95% level required for herd
protection, and high uptake in all neighbourhoods has
not been achieved consistently.13
In 2012, there was a large outbreak of measles, initially
concentrated in the Liverpool area, which subsequently
spread to surrounding communities in the North West
of England.14 Most cases occurred in older unvaccinated
children, or infants too young for vaccination. During
the outbreak, there were 651 laboratory-conﬁrmed cases,
of which 202 (31%) were born between 1995 and
2010.15
Population susceptibility to measles is dependent on
the uptake of MMR1 and MMR2, vaccine effectiveness,
immunity as a result of prior infection and protection by
maternal antibodies in infants. Therefore, using these
factors, it is possible to estimate population susceptibility
to measles using a well-deﬁned formula.16
We set out to estimate population susceptibility by
cohort of eligible children for MMR vaccination before
and after a large measles outbreak, using robust
individual-level immunisation records from the
Liverpool Child Health Information System (CHIS).17
METHODS
We used the CHIS data to undertake a retrospective
cohort study.
Study population
We established a birth cohort of children that were born
in Liverpool between 1 January 1995 and 31 December
2012 and were still resident in the city in 2014. We
included all children that were at least 13 months of age
and so were eligible for MMR1. We excluded children
under the age of 13 months as they were not eligible for
MMR vaccination in the UK.18 The full vaccination
history of those included was recorded prospectively
through CHIS.17 In the UK, the CHIS data set holds a
unique record for each child born in a deﬁned
geographical area up to the age of 18 years. Data from
the CHIS are used for a variety of child health services,
including immunisation services. We used codes within
the CHIS that allowed us to exclude stillbirths, children
who were born in the city but subsequently moved away
and children who were born outside but moved into the
city. The records include late vaccinations.
Uptake of MMR
We extracted pseudoanonymised data from CHIS,
including: unique identiﬁer; year and month of birth;
year and month of MMR1 vaccination; year and month
of MMR2 vaccination; and neighbourhood of residence
based on lower super output area.19
Population susceptibility to measles
WHO has set maximum guideline thresholds for popula-
tion susceptibility to measles based on age-structured
mixing models that are required to achieve elimination
of measles from the European region. Population sus-
ceptibility thresholds are based on age groups, with
maximum susceptibility thresholds being 15% in those
aged 1–4 years, 10% in those aged 5–9 years and 5% in
those aged over 10 years.20
Statistical analysis
To estimate annual birth cohort susceptibility to measles
before and after the outbreak, we calculated the
number of children who had not received MMR, those
who had received MMR1 only and those who had
received MMR1 and MMR2 at two deﬁned points in
time: 31 December 2011 for the preoutbreak calcula-
tions and 31 December 2013 for the postoutbreak calcu-
lations. To estimate population susceptibility, we used a
formula previously published based on WHO thresh-
olds.16
Susceptibility ¼ (Proportion with no MMR  100%)
þ (Proportion with MMR1 only  7%)
þ (Proportion with MMR2  3%)
We assumed vaccine efﬁcacy to be 93% and 97% for
the measles components of MMR1 and MMR2, respect-
ively.21 Although data were pseudoanonymised, we knew
from earlier work22 that conﬁrmed cases were most
likely not to have been vaccinated. Therefore, using
birth year and age of cases, we classiﬁed these children
as insusceptible for the calculation. Susceptibility was cal-
culated ﬁrst by birth year and then by age groups for
comparability with WHO guideline thresholds. We add-
itionally estimated susceptibility at the neighbourhood
level before and after the outbreak, and plotted on
neighbourhood maps. All data handling and statistical
analyses were performed using R V.3.1.2 (R
Development Core Team, Vienna, Austria).
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RESULTS
A total of 62 689 children were born and remained resi-
dent in Liverpool between 1995 and 2010. Using historical
case management records, we identiﬁed 10 laboratory-
conﬁrmed cases from prior to the outbreak cohort.
A total of 72 351 children were born and remained
resident in Liverpool between 1995 and 2012. In add-
ition to the 10 cases that were laboratory-conﬁrmed
before the outbreak, there were a further 240 laboratory-
conﬁrmed cases reported during the outbreak.
Preoutbreak population measles susceptibility
At 31 December 2011, 1 month before the outbreak
began, and including children born between 1995 and
2010, there were 4289 (6.8%) eligible children with no
MMR, 16 907 (27.0%) children with MMR1 only and
41 483 (66.2%) children who had received MMR1 and
MMR2. Across the population, susceptibility by birth
year ranged from 7.0% for children born in 1995 to
27.9% for children born in 2010 (ﬁgure 1).
In relation to ﬁgure 2 which presents susceptibility by
age group, preoutbreak susceptibility to measles was
above the WHO susceptibility threshold for children in
the 10+ years age group, at 8.6% (3.6% above the WHO
threshold). Susceptibility was 15% (at the WHO thresh-
old) for children born aged 1–4 years, and was 9.9%
(0.1% below the WHO threshold) for children aged
5–9 years. Additionally, when looking at individual birth
years, susceptibility was above the WHO thresholds in
those born in years between 1995 and 2003 (ﬁgure 1).
When we estimated susceptibility to measles by neigh-
bourhood of residence, preoutbreak population suscep-
tibility was above the threshold in: 267/291 (92%) in
the 10+ age group; 97/291 (33%) neighbourhoods in
the 1–4 years age group and 110/291 (38%) neighbour-
hoods in the 5–9 years age group (ﬁgure 3 and table 1).
Postoutbreak population measles susceptibility
After the outbreak, there were 4390 (6.1%) children
with no MMR, 18 027 (25.0%) children with MMR1 only
and 49 684 (68.9%) children with MMR1 and MMR2.
Across this eligible population, susceptibility by birth
year ranged from 6.4% for those born in 2008 to 28.4%
for those born in 2012 (ﬁgure 1).
In relation to ﬁgure 2, postoutbreak susceptibility
remained above the WHO susceptibility threshold among
children in the 10+ years age group at 8.5% (3.5% above
the WHO threshold). Susceptibility was 14.9% (0.1%
below the WHO threshold) for children aged 1–4 years
and 7.7% (2.3% below the WHO threshold) for children
aged 5–9 years. When examining individual, birth year’s
susceptibility remained above WHO thresholds for those
born in years between 1995 and 2003 (ﬁgure 1).
By neighbourhood of residence, postoutbreak popula-
tion susceptibility to measles was above the susceptibility
threshold in: 269/291 (92%) neighbourhoods for chil-
dren aged 10 years and older; in 92/291 (32%) neigh-
bourhoods for children aged 1–4 years and in 57/291
(20%) neighbourhoods for children aged 5–9 years
(ﬁgure 3 and table 1).
Figure 1 Susceptibility preoutbreak and postoutbreak by birth year, estimated using Child Health Information System data.
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Changes in MMR vaccine uptake preoutbreak
and postoutbreak
Before and after the outbreak period, the percentage of
children with no MMR decreased from 6.8% (4289/
62 689) to 6.1% (4390/72 351), the percentage of chil-
dren with MMR1 only decreased from 27.0% (16 907/
62 689) to 25.0% (18 027/72 351) and the percentage
of children with MMR1 and MMR2 increased from
66.2% (41 483/62 689) to 68.7% (49 684/72 351).
DISCUSSION
Historically and in comparison to the England and Wales
average, Liverpool had high uptake of MMR vaccination;
however, evidence from vaccination records demon-
strated that there was a substantial pool of susceptible
children to sustain an outbreak that affected the city and
surrounding areas in 2012. Despite intensiﬁed vaccin-
ation campaigns during and following the outbreak, the
pool of susceptible children remains above WHO suscep-
tibility threshold, that is, large enough to sustain future
measles outbreaks, especially among older children.
During the outbreak, there were 651 conﬁrmed cases,
of which 281 (43%) were born between 1995 and 2010
inclusive. Some of the additional vaccinations that were
administered during 2012–2013 include: postexposure
prophylaxis; and for those younger eligible and unexposed
children, part of routine immunisations. These additional
vaccination campaigns reduced population susceptibility
for birth year cohorts and neighbourhoods, but it was
inadequate to provide population protection. Catch-up
campaigns have been more successful with children who
had already received one dose of MMR and were there-
fore already engaged with vaccination services. Campaigns
were less successful, however, with those children who had
no MMR; and particularly children over the age of 9 years.
Although NICE guidance on reducing the differences in
immunisation uptake has highlighted the need for priori-
tising vaccination for deprived populations,23 a recent
study in Liverpool has shown that children from most
deprived neighbourhoods are still least likely to receive
MMR vaccination.13 This also mirrors ﬁndings from the
present study, where susceptibility was clustered by neigh-
bourhood in the younger age groups, predominantly in
the deprived neighbourhoods of the city.
The main susceptible age group remains those aged
10 years and over, particularly those born between 2000
and 2003. One possible explanation for this is the histor-
ically lower rates of MMR uptake in this age group as a
consequence of the 1998 MMR scare, and we hypothe-
sise that this group has not been effectively reached by
catch-up campaigns. Older children are particularly vul-
nerable to measles as they move from childhood to
young adulthood and mix with new groups in different
congregate environments. According to the UK
Department of Education, over 90% of children over
the age of 16 years transited into further education and
∼65% of those over the age 19 transited into further
Figure 2 Susceptibility preoutbreak and postoutbreak by age groups, estimated using the Child Health Information System.
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educational studies.24 If the susceptibility pattern we
uncovered in this study is repeated across the country,
then it is possible that we are entering a period where
large pools of measles-susceptible individuals are enter-
ing further education settings where social mixing pat-
terns may be intense, and with high potential for
generating and sustaining measles outbreaks. Indeed, at
the time of writing (August 2016), there are already
cases of measles in teenagers and young people linked
to music festivals in the UK where this age group is pre-
dominant and mixing patterns are intense.25 26
Moreover, children from this age group who go on to
enter employment in educational or healthcare settings
may mix with highly vulnerable infants too young to be
vaccinated.
The CHIS data contain individual-level records and
vaccination status of all children residing within the city.
Therefore, with targeted vaccination campaigns speciﬁc-
ally aimed at groups and neighbourhoods where
susceptibility is highest, it is possible to mitigate the risk
of future measles outbreaks among populations with the
greatest susceptibility. Work with local NHS and public
health services to implement this approach is currently
in progress.
Strengths and weaknesses
This study has a number of strengths including the use
of a robust, prospectively collected data set comprising
of individual-level data of over 70 000 children over a
period of 18 years. This allowed us to estimate measles
susceptibility before and after a large outbreak.
Furthermore, the study design uses a simple, repeatable
and resource light data source and methodology for esti-
mating local area level susceptibility of vaccine prevent-
able diseases that could be used by researchers, public
health commissioners and policymakers across the UK.
However, we excluded infants too young for MMR1
under 13 months of age at each time point as they
were not eligible to receive MMR vaccination (∼5000 in
total). It is acknowledged that maternal antibodies
provide measles protection, but this wanes during the
ﬁrst year of life. Therefore, it is possible that some of
these infants, particularly those over the age of 6 months,
may be susceptible.27 Further modelling could estimate
the effect of including these infants, in addition to
expanding analysis to account for age–sex and geospatial
mixing patterns.16 Although immunisation data held by
CHIS are more up to date and timely than COVER data,
there may be delays in the reporting of information from
GP practices to CHIS; however, this is unlikely to be sig-
niﬁcant to impact on WHO susceptibility thresholds for
this analysis.
Implications for policymakers/immunisation
commissioners
Responding to measles outbreaks is extremely challen-
ging and costly for health services. The total cost of the
Liverpool measles outbreak was estimated to be £4.4
million, whereas the cost of providing all missing MMR
vaccinations over the 5 years prior to the outbreak would
have been ∼4% of the cost of the outbreak.28 Therefore,
commissioners and policymakers need to urgently con-
sider the need for robust and well-resourced vaccination
programmes to improve vaccination uptake rates in
order to consistently achieve herd protection across all
settings and population groups.
CONCLUSIONS
Using robust vaccination records for children born
between 1995 and 2012, we have established that popula-
tion susceptibility to measles remains high and has only
diminished slightly since the outbreak. Therefore, this
cohort remains vulnerable to future outbreaks of
measles. Susceptible children and young adults who are
now beginning to enter higher and further education
and the workplace are vulnerable to contracting and
Figure 3 Measles susceptibility in Liverpool preoutbreak and
postoutbreak by age groups and neighbourhood, estimated
using Child Health Information System data.
Table 1 Number and percentage of neighbourhoods
above WHO measles susceptibility thresholds by age
group (n=291), estimated using the Child Health
Information System
Age groups Preoutbreak (%) Postoutbreak (%)
1–4 97 (33.3) 92 (31.6)
5–9 110 (37.8) 57 (19.6)
10+ 267 (91.8) 269 (92.4)
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spreading measles infection. Therefore, further public
health measures such as targeted and timely catch-up vac-
cination campaigns to reduce the level of susceptible
population are needed if we are going to prevent future
measles outbreaks.
RECOMMENDATIONS
Catch-up campaigns in local areas, such as Liverpool,
aimed towards young adults entering higher and further
education establishments are required as a matter of
urgency. This could be combined with existing routine
higher education vaccination campaigns such as vaccin-
ation against meningococcal disease. For those young
adults who neither engage in further/higher education,
nor enter employment, a catch-up campaign before
leaving school needs to be considered.
Following the catch-up campaigns, and in order to main-
tain improved uptake rates, there is a need for a robust
system in schools (school entry and school leaving immun-
isation checks) to be established and strengthened.
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